Literature DB >> 9858149

A case of mu heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test.

M Witzens1, G Egerer, D Stahl, E Werle, H Goldschmidt, R Haas.   

Abstract

We report here for the first time a patient with mu heavy-chain disease (HCD), hyperimmunoglobulinemia, and a positive direct antiglobulin test (DAT, Coombs test). The heavy-chain diseases involve the proliferation of lymphoplasma cells of B cell origin and are characterized by the production of incomplete heavy chains devoid of light chains. The association of mu heavy-chain disease with either hyperglobulinemia or a positive DAT has not been reported in the literature to date. In this patient, immunofixation of serum proteins with monospecific antisera to alpha-, gamma-, mu,- or delta-chains and to kappa- and lambda-chains revealed a precipitation band with antibody to IgM, but not with kappa and lambda light-chain antibodies, indicating mu heavy-chain disease. Hyperglobulinemia was present, which is very uncommon for HCD. A DAT of the patient's red blood cells (RBC) was found to be strongly positive for anti-IgG but negative for anti-IgM, -IgA, -C3c, and -C3d. However, when the eluate from the patient's red blood cells was investigated with nephelometry, it was found to contain antigens reactive with anti-y as well with anti-mu-antiserum. When a DAT was performed with a randomly chosen test cell incubated with the eluate, the antibody-containing eluate was shown to react with anti-IgG as well as with anti-IgM-antiserum. In summary, the eluate from the patient's RBCs contained IgG and an immunoglobulin structure reactive with anti-IgM in an RBC agglutination assay as well as with anti-mu antiserum in a nephelometric investigation. Whether this IgM on the patient's erythrocytes is penta- or oligomeric, complete IgM, or the heavy chain cannot be concluded from these observations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858149     DOI: 10.1007/s002770050448

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

Review 1.  Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.

Authors:  Machi Yanai; Akinori Maeda; Naoko Watanabe; Naoshi Sugimoto; Akiko Matsushita; Kenichi Nagai; Tatsuo Oida; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 2.  Heavy chain disease.

Authors:  Thomas E Witzig; Dietlind L Wahner-Roedler
Journal:  Curr Treat Options Oncol       Date:  2002-06

Review 3.  Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.

Authors:  Roberto Ria; Franco Dammacco; Angelo Vacca
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.